TISSUE REGENIX GROUP PLC
TRX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BNTXR104
- LEI:
- 213800PNOD5UHQUFJI36
- Country:
- United Kingdom
- Address:
- Unit 3, Phoenix Court Lotherton Way, LS25 2GY Leeds
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Health Care Technology
Description
Tissue Regenix Group PLC is a leading international medical technology company focused on developing regenerative products for orthopedics and dental applications. Our mission: Restoring patient function and vitality. We utilize innovative platform technologies to transform patient care and deliver favorable health economic outcomes, aiming to lead in regenerative medicine science and innovation.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-03-18 08:00 |
Business and Financial Review
Company update
|
English | 11.5 KB | |
| 2025-01-30 08:00 |
Regulatory News Service
Full year trading update
|
English | 11.9 KB | |
| 2025-01-15 14:25 |
Major Shareholding Notification
Holding(s) in Company
|
English | 22.6 KB | |
| 2025-01-13 15:20 |
Major Shareholding Notification
Holding(s) in Company
|
English | 52.7 KB | |
| 2024-12-09 15:44 |
Major Shareholding Notification
Holding(s) in Company
|
English | 53.1 KB | |
| 2024-11-26 08:00 |
Regulatory News Service
Extended distribution agreement with Arthrex, Inc.
|
English | 9.2 KB | |
| 2024-11-20 15:07 |
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
|
English | 53.5 KB | |
| 2024-11-12 17:05 |
Regulatory News Service
Form 8 (OPD) (Tissue Regenix Group Plc)
|
English | 45.7 KB | |
| 2024-11-05 15:24 |
Regulatory News Service
Form 8.3 - Tissue Regenix Group PLC
|
English | 51.5 KB | |
| 2024-11-04 17:36 |
Regulatory News Service
Response to media speculation
|
English | 20.2 KB | |
| 2024-09-10 08:00 |
Interim Report
Interim results for the six months ended 30 June
|
English | 302.1 KB | |
| 2024-08-21 08:00 |
Regulatory News Service
Confirmation of results
|
English | 12.2 KB | |
| 2024-07-18 16:52 |
Regulatory News Service
Grant of share options
|
English | 38.6 KB | |
| 2024-07-16 08:00 |
Earnings Release
Half-Year Trading Update
|
English | 13.2 KB | |
| 2024-07-03 14:16 |
Major Shareholding Notification
Holding(s) in Company
|
English | 51.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Halma PLC | United Kingdom | HLMA | |
|
Immunovia | Sweden | IMMNOV | |
|
IMMUPHARMA PLC | United Kingdom | IMM | |
|
Inventionmed Spolka Akcyjna | Poland | INM | |
|
ITIM GROUP PLC | United Kingdom | IRON | |
|
iZafe Group AB | Sweden | IZAFE | |
|
KNIGHTS GROUP HOLDINGS PLC | United Kingdom | KGH | |
|
Koninklijke Philips N.V. | Netherlands (Kingdom of the) | PHIA | |
|
Kontigo Care AB | Sweden | KONT | |
|
KORE POTASH PLC | United Kingdom | KP2 |